연구동향 분석
박사

Inhibitory Effects of Sesamol on Melanin Biosynthesis in Melanocyte Cells and Zebrafish : Sesamol의 마우스 색소 세포와 제브라피쉬에서 멜라닌 생합성 억제 효과

백승화 2015년

논문상세정보
인용/피인용
' Inhibitory Effects of Sesamol on Melanin Biosynthesis in Melanocyte Cells and Zebrafish : Sesamol의 마우스 색소 세포와 제브라피쉬에서 멜라닌 생합성 억제 효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • antimelanogenic agents
  • cyclic adenosine monophosphate
  • melanin
  • mmicrophthalmia-associated transcription factor
  • sesamol
  • tyrosinase
  • zebrafish
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
437 0

0.0%

' Inhibitory Effects of Sesamol on Melanin Biosynthesis in Melanocyte Cells and Zebrafish : Sesamol의 마우스 색소 세포와 제브라피쉬에서 멜라닌 생합성 억제 효과' 의 참고문헌

  • Zhong S, Wu Y, Soo-Mi A, Zhao J, Wang K, Yang S, Jae-Ho Y, ZhuX. 2006. Depigmentation of melanocytes by the treatment of extractsfrom traditional Chinese herbs: a cell culture assay. Biol. Pharm. Bull. 2006 29: 1947-1951.
  • Yasumoto K, Yokoyama K, Takahashi K, Tomita Y, Shibahara S. 1997. Functional analysis of microphthalmia-associated transcription factor inpigment cell-specific transcription of the human tyrosinase familygenes. J. Biol. Chem. 272: 503-509.
  • Yang YM, Son YO, Lee SA, Jeon YM, Lee JC. 2011, Quercetin inhibitsa-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytother. Res. 25: 1166-1173.
  • Yamaguchi Y, Passeron T, Hoashi T, Watabe H, Rouzaud F, YasumotoK, Hara T, Tohyama C, Katayama I, Miki T, Hearing VJ. 2008. Dickkopf 1 (DKK1) regulates skin pigmentation and thickness byaffecting Wnt/beta-catenin signaling in keratinocytes. FASEB J. 22:1009-1020.
  • Yamaguchi Y, Hearing VJ. 2009. Physiological factors that regulate skinpigmentation. Biofactors 35: 193-199.
  • Yamaguchi Y, Brenner M, Hearing VJ. 2007. The regulation of skinpigmentation. J. Biol. Chem. 282: 27557-27561.
  • Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET, MedranoEE. 2000. Regulation of microphthalmia-associated transcription factorMITF protein levels by association with the ubiquitin-conjugatingenzyme hUBC9. Exp. Cell Res. 255: 135-143.
  • Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, PriceER, Fisher DZ, Fisher DE. 2000. c-Kit triggers dualphosphorylations, which couple activation and degradation of theessential melanocyte factor Mi. Genes Dev. 14: 301-312.
  • Wrze?niok D, Beberok A, Otr?ba M, Buszman E. 2013. Effect ofstreptomycin on melanogenesis and antioxidant status in melanocytes. Mol. Cell Biochem. 383: 77-84.
  • Wood JM, Schallreuter KU. 1991. Studies on the reactions betweenhuman tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochim. Biophys. Acta 1074: 378-385.
  • Wiechers JW, Rawlings AV, Garcia C, Chesne C, Balaguer P, NicolasJC, Corre S, Galibert MD. 2005. A new mechanism of action forskin whitening agents: binding to the peroxisome proliferator-activatedreceptor. Int. J. Cosmet. Sci. 27: 123-132.
  • Widlund HR, Horstmann MA, Price ER, Cui J, Lessnick SL, Wu M, HeX, Fisher DE. 2002. Beta-catenin-induced melanoma growth requiresthe downstream target microphthalmia-associated transcription factor. JCell Biol. 158: 1079-1087.
  • White RM, Zon LI. 2008. Melanocytes in development, regeneration, andcancer. Cell Stem Cell 3: 242-252.
  • Westerfield M. The Zebrafish Book. 1995. A guide for laboratory use ofzebrafish (Danio rerio). University of Oregon Press: Eugene.
  • Wester RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, Quan D,Maibach HI. 1998. Human in vivo and in vitro hydroquinone topicalbioavailability, metabolism, and disposition. J. Toxicol. Environ. Health A 54: 301-317.
  • We SY, Pan SL, Xiao ZY, Hsu JL, Hsu JL, Chen MC, Lee KH, TengCM. 2014. NPRL-Z-1, as a new topoisomerase II poison, inducescell apoptosis and ROS generation in human renal carcinoma cells. PLoS One. 9: e112220.
  • Warra, AA. 2011. Sesame (Sesamun indicum L.) seed oil methods ofextraction and its prospects in cosmetic industry: a review. BayeroJournal of Pure and Applied Sciences 4: 164-168.
  • Wang TJ, An J, Chen XH, Deng QD, Yang L. 2014. Assessment ofCuscuta chinensis seeds effect on melanogenesis: comparison of waterand ethanol fractions in vitro and in vivo. J. Ethnopharmacol. 154:240-248.
  • Wang HM, Chen CY, Wen ZH. 2011. Identifying melanogenesis inhibitorsfrom Cinnamomum subavenium with in vitro and in vivo screeningsystems by targeting the human tyrosinase. Exp. Dermatol. 20:242-248.
  • Wanachewin O, Boonmaleerat K, Pothacharoen P, Reutrakul V,Kongtawelert P. 2012. Sesamin stimulates osteoblast differentiationthrough p38 and ERK1/2 MAPK signaling pathways. BMCComplement. Altern. Med. 12: 71-79.
  • Videira IF, Moura DF, Magina S. 2013. Mechanisms regulatingmelanogenesis. An. Bras. Dermatol. 88: 76-83.
  • Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L,Garcia-Lopez, M. 1989. Double-blind comparison of azelaic acid andhydroquinone in the treatment of melasma. Acta. Dermatol. Venereol. 143: 58-61.
  • Um MY, Ahn JY, Kim MK, Ha TY. 2012. Sesaminol glucosides protectbeta-amyloid induced apoptotic cell death by regulating redox systemin SK-N-SH cells. Neurochem. Res. 37: 689-699.
  • Tsang TF, Ye Y, Tai WC, Chou GX, Leung AK, Yu ZL, Hsiao WL. 2012. Inhibition of the p38 and PKA signaling pathways is associatedwith the anti-melanogenic activity of Qian-wang-hong-bai-san, aChinese herbal formula, in B16 cells. J. Ethnopharmacol. 141:622-628.
  • Trattner S, Kamal-Eldin A, Brannas E, Moazzami A, Zlabek V, LarssonP, Ruyter B, Gj en T, Pickova J. 2008. Sesamin supplementationincreases white muscle docosahexaenoic acid (DHA) levels inrainbow trout (Oncorhynchus mykiss) fed high alpha-linolenic acid(ALA) containing vegetable oil: metabolic actions. Lipids 43:989-997.
  • Tran, TT, Schulman J, Fisher DE. 2008. UV and pigmentation: molecularmechanisms and social controversies. Pigment Cell Melanoma Res. 21: 509-516.
  • Tomita K, Oda N, Ohbayashi M, Kamei H, Miyaki T, Oki T. 1990. Anew screening method for melanin biosynthesis inhibitors usingStreptomyces bikiniensis. J. Antibiot. (Tokyo) 43: 1601-1605.
  • Tomimori N, Tanaka Y, Kitagawa Y, Fujii W, Sakakibara Y, Shibata H. 2013. Pharmacokinetics and safety of the sesame lignans, sesaminand episesamin, in healthy subjects. Biopharm. Drug Dispos. 34:462-473.
  • Tokusoglu O, Kocak S, Aycan S. 2009. The contents of sesamol andrelated lignans in sesame, tahina and halva as determined by a newlydeveloped polarographic and stripping voltametric analysis. Grasas. Y. Aceites. 60: 119-124.
  • Tian J, Zhang R, Zhang H, Liu Y, Niu Y, Zhao L, Wang L, Guo H. 2014. Protective effect of sesamin against myocardial injury inducedby cadmium chloride in rats. Zhonghua Lao Dong Wei Sheng Zhi YeBing Za Zhi. 32: 357-360.
  • Thompson MS, Keith VM. 2001. The blacker the berry: gender, skintone, self-esteem, and self-efficacy. Gender & Society 15: 336-357.
  • Thody AJ, Graham A. 1998. Does alpha-MSH have a role in regulatingskin pigmentation in humans? Pigment Cell Res. 11: 265-274.
  • Taylor KL, Grant NJ, Temperley ND, Patton EE. 2010. Small moleculescreening in zebrafish: an in vivo approach to identifying newchemical tools and drug leads. Cell Commun. Signal. 8: 1-14.
  • Tachibana M. 2000. MITF: a stream flowing for pigment cells. PigmentCell Res. 13: 230-240.
  • Suja KP, Abraham JT, Thamizh SN, Jayalekshmy A, Arumughan C. 2004. Antioxidant efficacy of sesame cake extract in vegetable oilprotection. Food Chem. 84: 393-400.
  • Su TR, Lin JJ, Tsai CC, Huang TK, Yang ZY, Wu MO, Zheng YQ, SuCC, Wu YJ. 2013. Inhibition of melanogenesis by gallic acid:possible involvement of the PI3K/Akt, MEK/ERK and Wnt/b-cateninsignaling pathways in B16F10 cells. Int. J. Mol. Sci. 14:20443-20458.
  • Srisayam M, Weerapreeyakul N, Barusrux S, Kanokmedhakul K. 2014. Antioxidant, antimelanogenic, and skin-protective effect of sesamol. J. Cosmet. Sci. 65: 69-79.
  • Solano F, Briganti S, Picardo M, Ghanem G. 2006. Hypopigmentingagents: an updated review on biological, chemical and clinicalaspects. Pigment Cell Res. 19: 550-571.
  • Smit N, Vicanova J, Pavel S. 2009. The hunt for natural skin whiteningagents. Int. J. Mol. Sci. 10: 5326-5349.
  • Smit N, Vicanova J, Cramers P, Vrolijk H, Pavel S. 2004. The combinedeffects of extracts containing carotenoids and vitamins E and C ongrowth and pigmentation of cultured human melanocytes. SkinPharmacl. Physiol. 17: 238-245.
  • Simmler C, Pauli GF, Chen SN. 2013. Phytochemistry and biologicalproperties of glabridin. Fitoterapia. 90: 160-184.
  • Shin SH, Lee YM. 2013. Glyceollins, a novel class of soybeanphytoalexins, inhibit SCF-induced melanogenesis through attenuationof SCF/c-kit downstream signaling pathways. Exp. Mol. Med. 45:e17.
  • Seo DH, Jung JH, Lee JE, Jeon EJ, Kim W, Park CS. 2012. Biotechnological production of arbutins (a-and b-arbutins),skin-lightening agents, and their derivatives. Appl. Microbiol. Biotechnol. 95: 1417-1425.
  • Schonthaler HB, Fleisch VC, Biehlmaier O, Makhankov Y, Rinner O,Bahadori R, Geisler R, Schwarz H, Neuhauss SC, Dahm R. 2008. The zebrafish mutant lbk/vam6 resembles human multisystemicdisorders caused by aberrant trafficking of endosomal vesicles. Development 135: 387-399.
  • Sato K, Takahashi H, Iraha R, Toriyama M. 2008. Down-regulation of tyrosinase expression by acetylsalicylic acidin murine B16 melanoma. Biol. Pharm. Bull. 31: 33-37.
  • Sato K, Morita M, Ichikawa C, Takahashi H, Toriyama M. 2008. Depigmenting mechanisms of all-trans retinoic acid and retinol onB16 melanoma cells. Biosci. Biotechnol. Biochem. 72: 2589?2597.
  • Saint-Leger D. 2012. 'Cosmeceuticals'. Of men, science and laws…. Int. J. Cosmet. Sci. 34: 396-401.
  • Sadeghi N, Oveisia MR, Hajimahmoodia M, Jannatb B, Mazaheria M,Mansouri S. 2009. The contents of sesamol in iranian sesame seeds. Iranian J. Pharmaceutical Res. 8: 101-105.
  • Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users andfor biologist programmers. Methods Mol. Biol. 132: 365-386.
  • Rouzaud F, Annereau JP, Valencia JC, Costin GE, Hearing VJ. 2003.
  • Rogi T, Tomimori N, Ono Y, Kiso Y. 2011. The mechanism underlyingthe synergetic hypocholesterolemic effect of sesamin and α-tocopherolin rats fed a high-cholesterol diet. J. Pharmacol. Sci. 115: 408-416.
  • Riley PA. 1997. Melanin. Int. J. Biochem. Cell Biol. 29: 1235-1239.
  • Regulation of melanocortin 1 receptor expression at the mRNA andprotein levels by its natural agonist and antagonist. FASEB J. 17:2154-2156.
  • Rao. Fu, Yuting. Zhang, Yiran. Guo, Fang. Chen. 2014. Antioxidant andtyrosinase inhibition activities of the ethanol-insoluble fraction ofwater extract of Sapium sebiferum(L.) Roxb. Leaves. South Afri. J. Botany 93: 98?04.
  • Ramachandran S, Rajendra Prasad N, Karthikeyan S. 2010. Sesamolinhibits UVB-induced ROS generation and subsequent oxidativedamage in cultured human skin dermal fibroblasts. Arch. Dermatol. Res. 302: 733-744.
  • Rajaratnam R, Halpern J, Salim A, Emmett C. 2010. Interventions formelasma. Cochrane Database Syst. Rev. 7: JohnWiley & Sons, Ltd.
  • Raghavan AK, Pal A, Khanum F, Singh BA. 2010. Nutritional, medicinaland industrial uses of sesame (Sesamum indicum L.) seeds - anoverview. Agric. Conspectus Scientificus (ACS) 75: 159-168.
  • Quigley IK, Parichy DM. 2002. Pigment pattern formation in zebrafish: amodel for developmental genetics and the evolution of form. MicroscRes. Tech. 58: 442-455.
  • Price ER, Horstmann MA, Wells AG, Weilbaecher KN, Takemoto CM,Landis MW, Fisher DE. 1998. Alpha-melanocyte-stimulating hormonesignaling regulates expression of microphthalmia, a gene deficient inWaardenburg syndrome. J. Biol. Chem. 273: 33042-33047.
  • Praetorius C, Sturm RA, Steingrimsson E. 2014. Sun-induced freckling:ephelides and solar lentigines. Pigment Cell Melanoma Res. 27:339-350.
  • Pillaiyar T, Manickam M, Jung SH. 2015. Inhibitors of melanogenesis: apatent review (2009 - 2014). Expert. Opin. Ther. Pat. 4:1-14.
  • Phung B, Sun J, Schepsky A, Steingrimsson E, Ronnstrand L. 2011. C-KIT signaling depends on microphthalmia-associated transcriptionfactor for effects on cell proliferation. PLoS One. 6:e24064.
  • Pathak N, Rai AK, Kumari R, Bhat KV. 2014. Value addition in sesame:A perspective on bioactive components for enhancing utility. Pharmacogn. Rev. 8: 147-155.
  • Park HY, Wu C, Yonemoto L, Murphy-Smith M, Wu H, Stachur CM,Gilchrest BA. 2006. MITF mediates cAMP-induced protein kinaseC-beta expression in human melanocytes. Biochem. J. 395: 571-578.
  • Parhira S, Yang ZF2, Zhu GY1, Chen QL2, Zhou BX2, Wang YT2, LiuL1, Bai LP1, Jiang ZH. 2014. In vitro anti-influenza virus activitiesof a new lignan glycoside from the latex of Calotropis gigantea. PLoS One. 9: e104544.
  • Panda SK. 2014. Screening methods in the study of antimicrobialproperties of medicinal plants. Int. J. Biotech. Res. 2: 1-35.
  • Palumbo A, d'Ischia M, Misuraca G, Prota G. 1991. Mechanism ofinhibition of melanogenesis by hydroquinone. Biochim. Biophys. Acta1073: 85-90.
  • Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, Seiberg M. 2001. An alternative approach to depigmentation by soybean extracts viainhibition of the PAR-2 pathway. J. Invest. Dermatol. 116: 587-595.
  • Ou B, Hampsch-Woodill M, Prior RL. (2001). Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe, J Agric Food Chem, 49;4619-4626
  • Oh MJ, Hamid MA, Ngadiran S, Seo YK, Sarmidi MR, Park CS. 2011. Ficus deltoidea (Mas cotek) extract exerted anti-melanogenic activityby preventing tyrosinase activity in vitro and by suppressingtyrosinase gene expression in B16F1 melanoma cells. Arch. Dermatol. Res. 303: 161-170.
  • Ng LT, Lin LT, Chen CL, Chen HW, Wu SJ, Lin CC. 2014. Anti-melanogenic effects of δ-tocotrienol are associated withtyrosinase-related proteins and MAPK signaling pathway in B16melanoma cells. Phytomedicine 21: 978-983.
  • Nerya O, Vaya J, Musa R, Izrael S, Ben-Arie R, Tamir S. 2003. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licoriceroots. J. Agric. Food Chem. 51: 1201?1207.
  • Nasti TH, Timares L. 2015. MC1R, eumelanin and pheomelanin: their rolein determining the susceptibility to skin cancer. Photochem. Photobiol. 91: 188-200.
  • Namiki M. 1995. The chemistry and physiological functions of sesame. Food Rev. Int. 11: 281?329.
  • Namayandeh SM, Kaseb F, Lesan S. 2013. Olive and sesame oil effecton lipid profile in hypercholesterolemic patients, which better? Int. J. Prev. Med. 4: 1059-1062.
  • Nagata H, Takekoshi S, Takeyama R, Homma T, Yoshiyuki Osamura R. 2004. Quercetin enhances melanogenesis by increasing the activityand synthesis of tyrosinase in human melanoma cells and in normalhuman melanocytes. Pigment Cell. Res. 17: 66-73.
  • Monteiro EM, Chibli LA, Yamamoto CH, Pereira MC, Vilela FM,Rodarte MP, Pinto MA, do Amaral Mda P, Silverio MS, Araujo AL,de Araujo Ada L, Del-Vechio-Vieira G, de Sousa OV. 2014. Antinociceptive and anti-inflammatory activities of the sesame oil andsesamin. Nutrients 6: 1931-1944.
  • Minwalla L, Zhao Y, Cornelius J, Babcock GF, Wickett RR, Poole IC,Boissy RE. Inhibition of melanosome transfer from melanocytes tokeratinocytes by lectins and neoglycoproteins in an in vitro modelsystem. Pigment Cell Res. 14: 185?194.
  • Millikan LE. 2001. Cosmetology, cosmetics, cosmeceuticals: definitions andregulations. Clin. Dermatol. 19: 371-374.
  • Mikami M, Sonoki T, Ito M, Funasaka Y, Suzuki T, Katagata Y. 2013. Glycosylation of tyrosinase is a determinant of melanin production incultured melanoma cells. Mol. Med. Rep. 8: 818-822.
  • Matoba Y, Kumagai T, Yamamoto A, Yoshitsu H, Sugiyama M. 2006. Crystallographic evidence that the dinuclear copper center oftyrosinase is flexible during catalysis. J. Biol. Chem. 281: 8981-8990.
  • Masuda A, Eguchi G. 1984. Phenylthiourea enhances Cu cytotoxicity incell cultures: its mode of action. Cell Struct. Funct. 9: 25-35.
  • Logan DW, Burn SF, Jackson IJ. 2006. Regulation of pigmentation inzebrafish melanophores. Pigment Cell Res. 19: 206-213.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression datausing real-time quantitative PCR and the 2 (-Delta Delta CT) MethodMethods 25: 402-408.
  • Liu JJ, Fisher DE. 2010. Lighting a path to pigmentation: mechanisms ofMITF induction by UV. Pigment Cell Melanoma Res. 23: 741-745.
  • Lintner K, Mas-Chamberlin C, Mondon P, Peschard O, Lamy L. 2009. Cosmeceuticals and active ingredients. Clin. Dermatol. 27: 461-468.
  • Lin CH, Shen ML1, Kao ST2, Wu DC. 2014. The effect of sesamin onairway fibrosis in vitro and in vivo. Int. Immunopharmacol. 22:141-150.
  • Li EH, Min HJ, Belk RW, Kimura J, Bahl S. 2008. Skin lightening andbeauty in four asian cultures. Adv. Consumer Res. 35: 444-449.
  • Lemic-Stojcevic L, Nias AH, Breathnach AS. 1995. Effect of azelaicacid on melanoma cells in culture. Exp. Dermatol. 4: 79?81.
  • Lehraiki A, Abbe P, Cerezo M, Rouaud F, Regazzetti C, Chignon-SicardB, Passeron T, Bertolotto C, Ballotti R, Rocchi S. 2014. Inhibition ofmelanogenesis by the antidiabetic metformin. J. Invest. Dermatol. 134: 2589-2597.
  • Lee TH, Seo JO, Baek SH, Kim SY. 2014. Inhibitory effects ofresveratrol on melanin synthesis in ultraviolet B-induced pigmentationin guinea pig skin. Biomol. Ther. (Seoul). 222: 35-40.
  • Lee SY, Son DJ, Lee YK, Lee JW, Lee HJ, Yun YW, Ha TY, Hong JT. 2006. Inhibitory effect of sesaminol glucosides onlipopolysaccharide-induced NF-kappaB activation and target geneexpression in cultured rat astrocytes. Neurosci. Res. 56: 204-212.
  • Lee MH, Lin YP, Hsu FL, Zhan GR, Yen KY. 2006. Bioactiveconstituents of Spatholobus suberectus in regulating tyrosinase-relatedproteins and mRNA in HEMn cells. Phytochemistry 67: 1262-1270.
  • Lee J, Lee Y, Choe E. 2008. Effect of sesamol, sesamin, and sesamolinextracted from roasted sesame on the thermal oxidation of methyllinoleate. LWT- Food Sci. Technol. 41: 1871?1875.
  • Lee J, Jung K, Kim YS, Park D. 2007. Diosgenin inhibits melanogenesisthrough the activation of phosphatidylinositol-3-kinase pathway (PI3K)signaling. Life Sci. 81: 249-254.
  • Lee J, Jung E, Park J, Jung K, Park E, Kim J, Hong S, Park J, Park S,Lee S, Park D. 2005. Glycyrrhizin induces melanogenesis byelevating a cAMP level in b16 melanoma cells. J. Invest. Dermatol. 124: 405-411.
  • Lee AY, Noh M. 2013. The regulation of epidermal melanogenesis viacAMP and/or PKC signaling pathways: insights for the developmentof hypopigmenting agent. Arch. Pharm. Res. 36: 792-801.
  • Lapi D, Di Maro M, Mastantuono T, Battiloro L, Sabatino L, MuscarielloE, Colantuoni A. 2015. Effects of oleuropein and pinoresinol onmicrovascular damage induced by hypoperfusion and reperfusion inrat pial circulation. Microcirculation 22: 79-90.
  • Kumar N, Mudgal J, Parihar VK, Nayak PG, Kutty NG, Rao CM. 2013. Sesamol treatment reduces plasma cholesterol and triacylglycerollevels in mouse models of acute and chronic hyperlipidemia. Lipids48: 633-638.
  • Kumar CM, Singh SA. 2015. Bioactive lignans from sesame (Sesamumindicum L.): evaluation of their antioxidant and antibacterial effectsfor food applications. J. Food Sci. Technol. 52: 2934-2941.
  • Kumar CM, Sathisha UV, Dharmesh S, Rao AG, Singh SA. 2011. Interaction of sesamol (3,4-methylenedioxyphenol) with tyrosinase andits effect on melanin synthesis. Biochimie 93: 562-569.
  • Kumar CM, Appu Rao AG, Singh SA. 2009. Effect of infrared heatingon the formation of sesamol and quality of defatted flours fromSesamum indicum L. J. Food Sci. 74: H105-111.
  • Kudoh T, Tsang M, Hukriede NA, Chen X, Dedekian M, Clarke CJ,Kiang A, Schultz S, Epstein JA, Toyama R, Dawid IB. 2001. Agene expression screen in zebrafish embryogenesis. Genome Res. 11:1979-1987.
  • Ko HH, Chiang YC, Tsai MH, Liang CJ, Hsu LF, Li SY, Wang MC,Yen FL, Lee CW. 2014. Eupafolin, a skin whitening flavonoidisolated from Phyla nodiflora, downregulated melanogenesis: Role ofMAPK and Akt pathways. J. Ethnopharmacol. 151: 386-393.
  • Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev. Dyn. 203:253-310.
  • Kim KN, Yang HM, Kang SM, Kim D, Ahn G, Jeon YJ. 2013. Octaphlorethol A isolated from Ishige foliacea inhibitsa-MSH-stimulated induced melanogenesis via ERK pathway inB16F10 melanoma cells. Food Chem. Toxicol. 59: 521-526.
  • Kim JH, Baek SH, Kim DH, Choi TY, Yoon TJ, Hwang JS, Kim MR,Kwon HJ, Lee CH. 2008. Downregulation of melanin synthesis byhaginin A and its application to in vivo lightening model. J. Invest. Dermatol. 128: 1227-1235.
  • Kim JH, Baek EJ, Lee EJ, Yeom MH, Park JS, Lee KW, Kang NJ. 2015. Ginsenoside F1 attenuates hyperpigmentation in B16F10melanoma cells by inducing dendrite retraction and activating Rhosignalling. Exp. Dermatol. 24: 150-152.
  • Kim HJ, Kim SH. 2010. Tanshinone IIA enhances BMP-2-stimulatedcommitment of C2C12 cells into osteoblasts via p38 activation. Amino Acids 39: 1217-1226.
  • Kim ES, Chang H, Choi H, Shin JH, Park SJ, Jo YK, Choi ES, BaekSY, Kim BG, Chang JW, Kim JC, Cho DH. 2014. Autophagyinduced by resveratrol suppresses a-MSH-induced melanogenesis. Exp. Dermatol. 23: 204-206.
  • Kim DS, Park SH, Lee HK, Choo SJ, Lee JH, Song GY, Yoo ID, KwonSB, Na JI, Park KC. 2010. Hypopigmentary action ofdihydropyranocoumarin D2, a decursin derivative, as aMITF-degrading agent. J. Nat. Prod. 73: 797-800.
  • Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, Park KC. 2002.
  • Kim DS, Jeong YM, Park IK, Hahn HG, Lee HK, Kwon SB, Jeong JH,Yang SJ, Sohn UD, Park KC. 2007. A new 2-imino-1,3-thiazolinederivative, KHG22394, inhibits melanin synthesis in mouse B16melanoma cells. Biolog. Pharmaceutical Bull. 30: 180?183.
  • Kim DS, Hwang ES, Lee JE, Kim SY, Kwon SB, Park KC. 2003. Sphingosine-1-phosphate decreases melanin synthesis via sustainedERK activation and subsequent MITF degradation. J. Cell Sci. 116:1699-1706.
  • Kikugawa K. Arai M, Kurechi T. 1983 Participation of sesamol instability of sesame oil. J. Am. Oil. Chem. Soc. 60: 1528-1533.
  • Kelsh RN, Schmid B, Eisen JS. 2000. Genetic analysis of melanophoredevelopment in zebrafish embryos. Dev. Biol. 2225: 277-293.
  • Kasraee K. 2002. Depigmentation of brown guinea pig skin by topicalapplication of methimazole. J. Invest. Dermatol. 118: 205-207.
  • Kasraee B, Hugin A, Tran C, Sorg O, Saurat JH. 2004. Methimazole isan inhibitor of melanin synthesis in cultured B16 melanocytes. J. Invest. Dermatol. 122: 1338-1341.
  • Karin M, 1994. Signal transduction from the cell surface to the nucleusthrough the phosphorylation of transcription factors. Curr. Opin. CellBiol. 6: 415-424.
  • Karg E, Odh G, Wittbjer A, Rosengren E, Rorsman H. 1993. Hydrogenperoxide as an inducer of elevated tyrosinase level in melanomacells. J. Invest. Dermatol. 100: 209S-213S.
  • Kang MH, Naito M, Tsujihara N, Osawa T. 1998. Sesamolin inhibits lipidperoxidation in rat liver and kidney. J. Nutr. 128: 1018-1022.
  • Kameyama K, Sakai C, Kondoh S, Yonemoto K, Nishiyama S, TagawaM, Murata T, Ohnuma T, Quigley J, Dorsky A, Bucks D, BlanockK. 1996. Inhibitory effect of magnesium L-ascorbyl-2-phosphate(VC-PMG) on melanogenesis in vitro and in vivo. J. Am. Acad. Dermatol. 34: 29-33.
  • Kamal-Eldin A, Moazzami A, Washi S. 2011. Sesame seed lignans: potentphysiological modulators and possible ingredients in functional foods& nutraceuticals. Recent Pat. Food Nutr. Agric. 3: 17-29.
  • Kamal-Eldin A, Appelqvist LA. 1995. The effects of extraction methodson sesame oil stability. J. Am. Oil Chem. Soc. 72: 967-969.
  • Kamal-Eldin A, Appelqvist LA. 1994. Variations in the compositions ofsterols, tocopherols and lignans in seed oils from four sesamumspecies. J. Am. Oil Chem. Soc. 71: 149-156.
  • Kadekaro AL, Kanto H, Kavanagh R, Abdel-Malek Z. 2003. Significanceof the melanocortin 1 receptor in regulating human melanocytepigmentation, proliferation, and survival. Ann. N. Y. Acad. Sci. 994:359-365.
  • Jones K, Hughes J, Hong M, Jia Q, Orndorff S. 2002. Modulation ofmelanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res. 15: 335-340.
  • Jin KS, Oh YN, Hyun SK, Kwon HJ, Kim BW. 2014. Betulinic acidisolated from Vitis amurensis root inhibits 3-isobutyl-1-methylxanthineinduced melanogenesis via the regulation of MEK/ERK and PI3K/Aktpathways in B16F10 cells. Food Chem. Toxicol. 68: 38-43.
  • Jiang Z, Li S, Liu Y, Deng P, Huang J, He G. 2011. Sesamin inducesmelanogenesis by microphthalmia-associated transcription factor andtyrosinase up-regulation via cAMP signaling pathway. Acta. Biochim. Biophys. Sin. (Shanghai). 43: 763-770.
  • Jang JY, Kim HN, Kim YR, Choi WY, Choi YH, Shin HK, Choi BT. 2011. Partially purified components of Nardostachys chinensissuppress melanin synthesis through ERK and Akt signaling pathwaywith cAMP down-regulation in B16F10 cells. J. Ethnopharmacol. 137: 1207-1214.
  • Ishihara Y, Oka M, Tsunakawa M, Tomita K, Hatori M, Yamamoto H,Kamei H, Miyaki T, Konishi M, Oki T. 1991. Melanostatin, a newmelanin synthesis inhibitor. Production, isolation, chemical properties,structure and biological activity. J. Antibiot. (Tokyo). 44: 25-32.
  • Ide T, Nakashima Y, Iida H, Yasumoto S, Katsuta M. 2009. Lipidmetabolism and nutrigenomics-impact of sesame lignans on geneexpression profiles and fatty acid oxidation in rat liver. Forum Nutr. 61: 10-24.
  • Huang HC, Chou YC, Wu CY, Chang TM. 2013. [8]-Gingerol inhibitsmelanogenesis in murine melanoma cells through down-regulation ofthe MAPK and PKA signal pathways. Biochem. Biophy. Res. Comm. 438: 375-381.
  • Hou RC, Wu CC, Huang JR, Chen YS, Jeng KC. 2005. Oxidativetoxicity in BV-2 microglia cells: sesamolin neuroprotection of H2O2injury involving activation of p38 mitogen-activated protein kinase. Ann. NY Acad. Sci. 1042: 279-285.
  • Hirose N1, Doi F, Ueki T, Akazawa K, Chijiiwa K, Sugano M, AkimotoK, Shimizu S, Yamada H. 1992. Suppressive effect of sesaminagainst 7,12-dimethylbenz[a]-anthracene induced rat mammarycarcinogenesis. Anticancer Res. 12: 1259-1265.
  • Hideya A, Hirofumi K, Masamitsu, Vincent JH. 2007. Approaches toidentify inhibitors of melanin biosynthesis via the quality control oftyrosinase. J. Invest. Dermatol. 127: 751?761.
  • Hida T, Wakamatsu K, Sviderskaya EV, Donkin AJ, Montoliu L, LynnLamoreux M, Yu B, Millhauser GL, Ito S, Barsh GS, Jimbow K,Bennett DC. 2009. Agouti protein, mahogunin, and attractin inpheomelanogenesis and melanoblast-like alteration of melanocytes: acAMP-independent pathway. Pigment Cell Melanoma Res. 22:623-634.
  • Hearing VJ. 2011. Determination of melanin synthetic pathways. J. Invest. Dermato. 17: E8?E11.
  • Hamada N, Tanaka A, Fujita Y, Itoh T, Ono Y, Kitagawa Y, TomimoriN, Kiso Y, Akao Y, Nozawa Y, Ito M. 2011. Involvement of hemeoxygenase-1 induction via Nrf2/ARE activation in protection againstH2O2-induced PC12 cell death by a metabolite of sesamin containedin sesame seeds. Bioorg. Med. Chem. 19: 1959-1965.
  • Hall RE. 1995. The bleaching syndrome: african americans' response tocultural domination vis-a-vis skin color. J. Black Studies 26: 172-184.
  • Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, MiyamotoK, Greatens A, Hillebrand GG, Bissett DL, Boissy RE. 2002. Theeffect of niacinamide on reducing cutaneous pigmentation andsuppression of melanosome transfer. Br. J. Dermatol. 147: 20?31.
  • Hachiya A, Kobayashi A, Ohuchi A, Takema Y, Imokawa G. 2001. Theparacrine role of stem cell factor/c-kit signaling in the activation ofhuman melanocytes in ultraviolet-B-induced pigmentation. J. Invest. Dermatol. 116: 578-586.
  • Gupta A, Sharma S, Kaur I, Chopra K. 2009. Renoprotective effects ofwesamol in ferric nitrilotriacetate-induced oxidative renal injury inrats. Basic Clin. Pharmacol. Toxicol. 104: 316-321.
  • Guo J, Zhang JF, Wang WM, Cheung FW, Lu YF, Ng CF, Kung HF,Liu WK. 2014. MicroRNA-218 inhibits melanogenesis by directlysuppressing microphthalmia-associated transcription factor expression. RNA Biol. 11: 732-741.
  • Gillbro JM, Olsson MJ. 2011. The melanogenesis and mechanisms ofskin-lightening agents-existing and new approaches. Int. J. Cosmet. Sci. 33: 210-221.
  • Geetha T, Rohit B, Pal KI. 2009. Sesamol: an efficient antioxidant withpotential therapeutic benefits. Med. Chem. 5: 367-371.
  • Fu YT, Lee CW, Ko HH, Yen FL. 2014. Extracts of Artocarpuscommunis decrease α-melanocyte stimulating hormone-inducedmelanogenesis through activation of ERK and JNK signalingpathways. Scientific World J. 5: 1-8.
  • Freise C, Querfeld U. 2015. The lignan (+)-episesamin interferes withTNF-α-induced activation of VSMC via diminished activation ofNF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases. Acta. Physiol. (Oxf). 213: 642-652Fujii T, Saito M. 2009. Inhibitory effect of quercetin isolated from rosehip (Rosa canina L.) against melanogenesis by mouse melanomacells. Biosci. Biotechnol. Biochem. 73: 1989-1993.
  • Fang D, Tsuji Y, Setaluri V. 2002. Selective down-regulation of tyrosinasefamily gene TYRP1 by inhibition of the activity of melanocytetranscription factor, MITF. Nucleic Acids Res. 30: 3096-3106.
  • Englaro W, Rezzonico R, Durand-Clement M, Lallemand D, Ortonne JP,Ballotti R. 1995. Mitogen-activated protein kinase pathway and AP-1are activated during cAMP-induced melanogenesis in B-16 melanomacells. J. Biol. Chem. 270: 24315-24320.
  • Draelos ZD. 2007. Skin lightening preparations and the hydroquinonecontroversy. Dermatol. Ther. 20: 308-313.
  • Delayed ERK activation by ceramide reduces melanin synthesis inhuman melanocytes. Cell Signal. 14: 779-785.
  • Dastager SG, Li WJ, Dayanand A, Tang SK, Tian XP, Zhi XY, Xu LH,Jiang CL. 2006. Seperation, identification and analysis of pigment(melanin) production in Streptomyces. Afri. J. Biotech. 5: 1131-1134.
  • D'Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. 2013. UV radiation andthe skin. Int. J. Mol. Sci. 14: 12222-12248.
  • Criton M, Le Mellay-Hamon V. 2008. Analogues ofN-hydroxy-N'-phenylthiourea and N-hydroxy-N'-phenylurea as inhibitorsof tyrosinase and melanin formation. Bioorg. Med. Chem. Lett. 18:3607-3610.
  • Costin GE, Hearing VJ. 2007. Human skin pigmentation: melanocytesmodulate skin color in response to stress. FASEB J. 21: 976-994.
  • Corre S, Primot A, Sviderskaya E, Bennett DC, Vaulont S, Goding CR,Galibert MD. 2004. UV-induced expression of key component of thetanning process, the POMC and MC1R genes, is dependent on thep-38-activated upstream stimulating factor-1 (USF-1). J. Biol. Chem. 279: 51226-51233.
  • Colanesi S, Taylor KL, Temperley ND, Lundegaard PR, Liu D, North TE,Ishizaki H, Kelsh RN, Patton EE. 2012. Small molecule screeningidentifies targetable zebrafish pigmentation pathways. Pigment CellMelanoma Res. 25: 131-143.
  • Choi TY, Kim JH, Ko DH, Kim CH, Hwang JS, Ahn S, Kim SY, KimCD, Lee JH, Yoon TJ. 2007. Zebrafish as a new model forphenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res. 20: 120-127.
  • Chao HC, Najjaa H, Villareal MO, Ksouri R, Han J, Neffati M, Isoda H. 2013. Arthrophytum scoparium inbibitons melanogenesis throughthe down-regulation of tyrosinase and melanogenic geneexpressions in B16 melanoma cells. Exp. Dermatol. 22:131-136.
  • Chang TS. 2009. An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 10: 2440-2475.
  • Chang CC, Lu WJ, Ong ET, Chiang CW, Lin SC, Huang SY, Sheu JR. 2011. A novel role of sesamol in inhibiting NF-κB-mediatedsignaling in platelet activation. J. Bio. med. Sci. 18: 93-102.
  • Chakraborty AK, Funasaka Y, Komoto M, Ichihashi M. 1998. Effect ofarbutin on melanogenic proteins in human melanocytes. Pigment CellRes. 11: 206?212.
  • Cabanes J, Chazarra S, Garcia-Carmona F. 1994. Kojic acid, a cosmeticskin whitening agent, is a slow-binding inhibitor of catecholaseactivity of tyrosinase. J. Pharm. Pharmacol. 46: 982?985.
  • Busca R, Ballotti R. 2000. Cyclic AMP a key messenger in the regulationof skin pigmentation. Pigment Cell Res. 13: 60-69.
  • Briganti S, Camera E, Picardo M. 2003. Chemical and instrumentalapproaches to treat hyperpigmentation. Pigment Cell Res. 16: 101-110.
  • Brenner M, Hearing VJ. 2008. Modifying skin pigmentation- approachesthrough intrinsic biochemistry and exogenous agents. Drug Discov. Today Dis. Mech. 5: e189-e199.
  • Braasch I, Schartl M, Volff JN. 2007. Evolution of pigment synthesispathways by gene and genome duplication in fish. BMC Evol. Biol. 7: 74-92.
  • Braasch I, Liedtke D, Volff JN, Schartl M. 2009. Pigmentary function andevolution of tyrp1 gene duplicates in fish. Pigment Cell MelanomaRes. 22: 839-850.
  • Bin BH, Seo J, Yang SH, Lee E, Choi H, Kim KH, Cho EG, Lee TR. 2013. Novel inhibitory effect of the antidiabetic drug voglibose onmelanogenesis. Exp. Dermatol. 22: 541-546.
  • Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP,Ballotti R. 1998. Microphthalmia gene product as a signal transducerin cAMP-induced differentiation of melanocytes. J. Cell Biol. 142:827-835.
  • Bennett DC, Cooper PJ, Hart IR. 1987. A line of non-tumorigenic mousemelanocytes, syngeneic with the B16 melanoma and requiring atumour promoter for growth. Int. J. Cancer 39: 414-418.
  • Bennett DC, Cooper PJ, Dexter TJ, Devlin LM, Heasman J, Nester B. 1989. Cloned mouse melanocyte lines carrying the germline mutationsalbino and brown: complementation in culture. Development 105:379-385.
  • Benjamin CL, Melnikova VO, Ananthaswamy HN. 2007. Models andmechanisms in malignant melanoma. Mol. Carcinog. 46: 671-678.
  • Bellei B, Maresca V, Flori E, Pitisci A, Larue L, Picardo M. 2010. p38regulates pigmentation via proteasomal degradation of tyrosinase. J. Biol. Chem. 285: 7288-7299.
  • Bell AA, Wheeler MH. 1986. Biosynthesis and functions of fungalmelanins. Annu. Rev. Phytopathol. 24: 411?451.
  • Barsh GS. 1996. The genetics of pigmentation: from fancy genes tocomplex traits. Trends Genet. 12: 299-305.
  • Baek SH, Nam IJ, Kwak HS, Kim KC, Lee SH. 2015. Cellularanti-melanogenic effects of a Euryale ferox seed extract ethyl acetatefraction via the lysosomal degradation machinery. Int. J. Mol. Sci. 16: 9217-9235.
  • Baek S, Kim J, Kim D, Lee C, Kim J, Chung DK, Lee C. 2008. Inhibitory effect of dalbergioidin isolated from the trunk of Lespedezacyrtobotrya on melanin biosynthesis. J. Micro. Biotechnol. 18:874-879.
  • Ando H, Ryu A, Hashimoto A, Oka M, Ichashi M. 1998. Linoleic anda-linoleic acid lightens ultraviolet-induced hyperpigmentation of theskin. Arch. Dermatol. Res. 290: 375?381.
  • Ando H, Kondoh H, Ichihashi M, Hearing VJ. 2007. Approaches toidentify inhibitors of melanin biosynthesis via the quality control oftyrosinase. J. Invest. Dermatol. 127: 751-761.
  • Alesiani D, Cicconi R, Mattei M, Bei R, 2009. Canini A. Inhibition ofMek 1/2 kinase activity and stimulation of melanogenesis by5,7-dimethoxycoumarin treatment of melanoma cells. Int. J. Oncol. 34: 1727-1735.
  • Agar N, Young AR. 2005. Melanogenesis: a photoprotective response toDNA damage?. Mutation Res. 571: 121?132.
  • Abdel-Malek ZA, Scott MC, Furumura M, Lamoreux ML, Ollmann M,Barsh GS, Hearing VJ. 2001. The melanocortin 1 receptor is theprincipal mediator of the effects of agouti signaling protein onmammalian melanocytes. J. Cell Sci. 114: 1019-1024.
  • Abdel-Malek Z, Swope VB, Suzuki I, Akcali C, Harriger MD, Boyce ST,Urabe K, Hearing VJ. 1995. Mitogenic and melanogenic stimulationof normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. USA 92: 1789-1793.